Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Depot Medroxyprogesterone Versus Norethisterone Oenanthate for Long‐acting Progestogenic Contraception." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Pessaries__mechanical_devices__for_pelvic_organ_prolapse_in_women:_Cochrane_systematic_review. Accessed 28 March 2024.
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Pessaries__mechanical_devices__for_pelvic_organ_prolapse_in_women:_Cochrane_systematic_review. Accessed March 28, 2024.
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Pessaries__mechanical_devices__for_pelvic_organ_prolapse_in_women:_Cochrane_systematic_review
Depot Medroxyprogesterone Versus Norethisterone Oenanthate for Long‐acting Progestogenic Contraception [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Pessaries__mechanical_devices__for_pelvic_organ_prolapse_in_women:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
ID - 433863
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Pessaries__mechanical_devices__for_pelvic_organ_prolapse_in_women:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -